Eureka Growth Capital has led the buyout of Drugscan

November 2008 – England & Company served as the financial advisor to Eureka Growth Capital in the leveraged buyout of Drugscan, Inc. (“Drugscan”). Drugscan is a SAMHSA-certified forensic toxicology laboratory that specializes in substance abuse identification for private industry, local governments, law enforcement agencies, medical examiners, and coroners throughout the United States and Canada.